---
title: "Welcome | Kisqali®"
description: "Discover how KISQALI (ribociclib) can help support patients with HR+/HER2− early and advanced breast cancer. Learn more about treatment options for EBC and ABC by choosing the right indication."
canonical_url: "https://www.kisqali.com/"
meta:
  "og:description": "Discover how KISQALI (ribociclib) can help support patients with HR+/HER2− early and advanced breast cancer. Learn more about treatment options for EBC and ABC by choosing the right indication."
  "og:title": Welcome
---

For Healthcare Professionnals Outside the US

**In EBC & ABC **  
** NO NEWS IS GOOD NEWS **

# **Welcome ! **

KISQALI is proven in patients with HR+/HER2 - early and advanced breast cancer (EBC and ABC).  
**To find out more, start by choosing an indication.**

**OR**

---

## Sitemap

See the full [sitemap](/sitemap.md) for all pages.